Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2000 4
2001 6
2002 9
2003 2
2004 3
2005 5
2006 9
2007 15
2008 17
2009 10
2010 8
2011 11
2012 17
2013 17
2014 24
2015 34
2016 27
2017 33
2018 37
2019 31
2020 23
2021 38
2022 24
2023 29
2024 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

400 results

Results by year

Filters applied: . Clear all
Page 1
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Chételat G, et al. Among authors: drzezga a. Lancet Neurol. 2020 Nov;19(11):951-962. doi: 10.1016/S1474-4422(20)30314-8. Lancet Neurol. 2020. PMID: 33098804 Review.
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; Amyloid Biomarker Study Group; Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinn… See abstract for full author list ➔ Jansen WJ, et al. Among authors: drzezga a. JAMA. 2015 May 19;313(19):1924-38. doi: 10.1001/jama.2015.4668. JAMA. 2015. PMID: 25988462 Free PMC article.
Propranolol und Morbus Parkinson.
Dietlein M, Dietlein F, Drzezga A. Dietlein M, et al. Among authors: drzezga a. Nuklearmedizin. 2018 Feb;57(1):1-3. doi: 10.3413/Nukmed-0947-17-11. Epub 2018 Feb 21. Nuklearmedizin. 2018. PMID: 29536493 German. No abstract available.
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases.
Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A, Lammich S, Ribicic S, Tahirovic S, Willem M, Deussing M, Palleis C, Rauchmann BS, Gildehaus FJ, Lindner S, Spitz C, Franzmeier N, Baumann K, Rominger A, Bartenstein P, Ziegler S, Drzezga A, Respondek G, Buerger K, Perneczky R, Levin J, Höglinger GU, Herms J, Haass C, Brendel M. Xiang X, et al. Among authors: drzezga a. Sci Transl Med. 2021 Oct 13;13(615):eabe5640. doi: 10.1126/scitranslmed.abe5640. Epub 2021 Oct 13. Sci Transl Med. 2021. PMID: 34644146
Tau-imaging in neurodegeneration.
Bischof GN, Endepols H, van Eimeren T, Drzezga A. Bischof GN, et al. Among authors: drzezga a. Methods. 2017 Nov 1;130:114-123. doi: 10.1016/j.ymeth.2017.08.003. Epub 2017 Aug 5. Methods. 2017. PMID: 28790016 Review.
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.
Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, Brooks DJ, Darcourt J, Dickson JC, Douglas D, Drzezga A, Dubroff J, Ekmekcioglu O, Garibotto V, Herscovitch P, Kuo P, Lammertsma A, Pappata S, Peñuelas I, Seibyl J, Semah F, Tossici-Bolt L, Van de Giessen E, Van Laere K, Varrone A, Wanner M, Zubal G, Law I. Morbelli S, et al. Among authors: drzezga a. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1885-1912. doi: 10.1007/s00259-020-04817-8. Epub 2020 May 9. Eur J Nucl Med Mol Imaging. 2020. PMID: 32388612 Free PMC article.
Clinical Amyloid Imaging.
Mallik A, Drzezga A, Minoshima S. Mallik A, et al. Among authors: drzezga a. Semin Nucl Med. 2017 Jan;47(1):31-43. doi: 10.1053/j.semnuclmed.2016.09.005. Epub 2016 Nov 24. Semin Nucl Med. 2017. PMID: 27987555 Review.
Ablative Radioiodtherapie des Schilddrüsenkarzinoms.
Dietlein M, Drzezga A. Dietlein M, et al. Among authors: drzezga a. Nuklearmedizin. 2018 Aug;57(4):118-123. doi: 10.3413/Nukmed-0976-18-05. Epub 2018 Aug 20. Nuklearmedizin. 2018. PMID: 30125924 German. No abstract available.
400 results